Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy : A Retrospective Study
BACKGROUND: Drug-induced liver injury (DILI) secondary to ATT treatment (TB-DILI) is reported in 2-28% of patients. We present here a series of clinical cases of suspected DILI arising during antituberculosis treatment, studied with the aid of liver biopsy.
METHODS: this was a retrospective descriptive study including 10 tuberculosis patients who underwent liver biopsy for suspected TB-DILI at the "Lazzaro Spallanzani" Institute from 2017 to 2022.
RESULTS: Ten patients who underwent LB were extracted from the database and included in the retrospective study cohort. According to the clinical classification, eight patients had hepatocellular liver injury, one patient had cholestatic injury, and another had mixed-type injury. Histopathological diagnosis revealed liver damage due to DILI in 5/10 (50%) cases. In one case, liver biopsy showed necrotizing granulomatous hepatitis.
CONCLUSIONS: Severe and persistent elevation of hepatic transaminases, hepatic cholestasis despite discontinuation of therapy, and other suspected hepatic conditions are indications for liver biopsy, which remains a valuable tool in the evaluation of selected tuberculosis patients with suspected DILI for many reasons. However, the decision to perform a liver biopsy should be based on clinical judgment, considering the benefits and risks of the procedure.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Infectious disease reports - 15(2023), 6 vom: 28. Nov., Seite 735-746 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Gualano, Gina [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antitubercular drugs |
|---|
| Anmerkungen: |
Date Revised 24.12.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/idr15060066 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366225456 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366225456 | ||
| 003 | DE-627 | ||
| 005 | 20231227140733.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/idr15060066 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1237.xml |
| 035 | |a (DE-627)NLM366225456 | ||
| 035 | |a (NLM)38131879 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gualano, Gina |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Utility of Liver Biopsy in the Diagnosis and Management of Possible Drug-Induced Liver Injury in Patients Receiving Antituberculosis Therapy |b A Retrospective Study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.12.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a BACKGROUND: Drug-induced liver injury (DILI) secondary to ATT treatment (TB-DILI) is reported in 2-28% of patients. We present here a series of clinical cases of suspected DILI arising during antituberculosis treatment, studied with the aid of liver biopsy | ||
| 520 | |a METHODS: this was a retrospective descriptive study including 10 tuberculosis patients who underwent liver biopsy for suspected TB-DILI at the "Lazzaro Spallanzani" Institute from 2017 to 2022 | ||
| 520 | |a RESULTS: Ten patients who underwent LB were extracted from the database and included in the retrospective study cohort. According to the clinical classification, eight patients had hepatocellular liver injury, one patient had cholestatic injury, and another had mixed-type injury. Histopathological diagnosis revealed liver damage due to DILI in 5/10 (50%) cases. In one case, liver biopsy showed necrotizing granulomatous hepatitis | ||
| 520 | |a CONCLUSIONS: Severe and persistent elevation of hepatic transaminases, hepatic cholestasis despite discontinuation of therapy, and other suspected hepatic conditions are indications for liver biopsy, which remains a valuable tool in the evaluation of selected tuberculosis patients with suspected DILI for many reasons. However, the decision to perform a liver biopsy should be based on clinical judgment, considering the benefits and risks of the procedure | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a DILI diagnosis | |
| 650 | 4 | |a DILI management | |
| 650 | 4 | |a antitubercular drugs | |
| 650 | 4 | |a hepatotoxicity | |
| 650 | 4 | |a histology | |
| 650 | 4 | |a liver biopsy | |
| 650 | 4 | |a liver injury | |
| 700 | 1 | |a Zace, Drieda |e verfasserin |4 aut | |
| 700 | 1 | |a Mosti, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Mencarini, Paola |e verfasserin |4 aut | |
| 700 | 1 | |a Musso, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Libertone, Raffaella |e verfasserin |4 aut | |
| 700 | 1 | |a Cerva, Carlotta |e verfasserin |4 aut | |
| 700 | 1 | |a Goletti, Delia |e verfasserin |4 aut | |
| 700 | 1 | |a Rianda, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Del Nonno, Franca |e verfasserin |4 aut | |
| 700 | 1 | |a Falasca, Laura |e verfasserin |4 aut | |
| 700 | 1 | |a Palmieri, Fabrizio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infectious disease reports |d 2009 |g 15(2023), 6 vom: 28. Nov., Seite 735-746 |w (DE-627)NLM206505906 |x 2036-7430 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:6 |g day:28 |g month:11 |g pages:735-746 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/idr15060066 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 6 |b 28 |c 11 |h 735-746 | ||